Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 7Recruiting 3Unknown 1Not yet recruiting 1Approved for marketing 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 180Breast Neoplasms 173Carcinoma, Non-Small-Cell Lung 172Colorectal Neoplasms 104Stomach Neoplasms 80Pancreatic Neoplasms 78Lung Neoplasms 78Prostatic Neoplasms 74Melanoma 67Recurrence 65Leukemia, Myeloid, Acute 65Neoplasm Metastasis 64Multiple Myeloma 63Ovarian Neoplasms 61Carcinoma, Hepatocellular 61Advanced Solid Tumor 59Lymphoma 58Advanced Solid Tumors 56Solid Tumor 50Lymphoma, Non-Hodgkin 47Uterine Cervical Neoplasms 45Glioblastoma 44Lymphoma, B-Cell 39Leukemia 38Head and Neck Neoplasms 34Colonic Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Esophageal Neoplasms 30Urinary Bladder Neoplasms 29Squamous Cell Carcinoma of Head and Neck 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Pathologic Processes × Clear all
NCT04601584 2024-03-06

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

AO GENERIUM

Phase 1/2 Unknown
36 enrolled
LymphoidOther hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡